Warning: getimagesize(): http:// wrapper is disabled in the server configuration by allow_url_fopen=0 in /home/tvoitete/voiceofthe.net/wp-content/plugins/td-cloud-library/shortcodes/header/tdb_header_logo.php on line 786

Warning: getimagesize(http://voiceofthe.net/wp-content/uploads/2020/08/Voice-Of-The-Net-logo-300x50.png): failed to open stream: no suitable wrapper could be found in /home/tvoitete/voiceofthe.net/wp-content/plugins/td-cloud-library/shortcodes/header/tdb_header_logo.php on line 786

Warning: getimagesize(): http:// wrapper is disabled in the server configuration by allow_url_fopen=0 in /home/tvoitete/voiceofthe.net/wp-content/plugins/td-cloud-library/shortcodes/header/tdb_header_logo.php on line 786

Warning: getimagesize(http://voiceofthe.net/wp-content/uploads/2020/08/Voice-Of-The-Net-logo-300x50.png): failed to open stream: no suitable wrapper could be found in /home/tvoitete/voiceofthe.net/wp-content/plugins/td-cloud-library/shortcodes/header/tdb_header_logo.php on line 786

First Alzheimer Drug Tested And Approved In US

The U.S. Food and Drug Administration (FDA) has approved the first drug that has been shown to slow the course of Alzheimer’s disease.

Experiments have shown that Leqembi slows down the progression of the disease. The problem is that it is very expensive. Providing the drug for a year costs about $26,500 per year.

Leqembi received “expedited” FDA approval in January, but the regulator required a confirmatory test. The standard approval means that Leqembi will now be available under the government’s Medicare and Medicaid insurance programs. Since Alzheimer’s disease mostly affects the elderly, most patients with this disease will be able to receive treatment costs from the state program, which is intended for people over 65 years of age.

However, the drug is only approved for people with early forms of Alzheimer’s disease, mild cognitive impairment, or mild dementia who have been confirmed to have amyloid plaques in the brain. Experts estimate that this group makes up about one-sixth of the more than 6 million Americans currently diagnosed with Alzheimer’s disease.

The FDA claims that a drug that targets the underlying process of Alzheimer’s disease has shown clinical benefit and that it is a safe and effective treatment.

Latest articles

“Kingdom Come: Deliverance 2” Officially Announced

Warhorse studio has announced Kingdom Come: Deliverance 2, a sequel to the original 2018 game. As stated in the leak, the game...

Qualcomm To Release Snapdragon X Computer Processors on April 24

Qualcomm published on Twitter a short teaser video with laptops marked with the letter X, apparently hinting at the imminent presentation and...

The Authors Of Cities: Skylines II Admitt Failure

Representatives of the Colossal Order studio and the publisher Paradox Interactive have published an appeal to players related to the current problems...

Apple Was Forced To Remove WhatsApp And Telegram From The App Store In China

China has demanded that Apple remove a number of applications from the App Store, including instant messengers WhatsApp, Telegram, Signal, Line and...

Related articles

Leave a reply

Please enter your comment!
Please enter your name here